Trexquant Investment LP Harmony Biosciences Holdings, Inc. Transaction History

Trexquant Investment LP

$8.01 Billion
Q1 2025

A detailed history of Trexquant Investment LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 113,728 shares of HRMY stock, worth $4.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

113,728

Previous 175,574 35.23%

Holding current value

$4.03 Million

Previous $6.04 Million 37.53%

% of portfolio

0.05%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$32.18 - $40.46 $1.99 Million - $2.5 Million	-61,846 Reduced 35.23%	113,728 $3.77 Million
Q4 2024 Feb 12, 2025	BUY	$31.86 - $41.49 $5.59 Million - $7.28 Million	175,574 New	175,574 $6.04 Million
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $1.29 Million - $1.58 Million	42,259 Added 277.86%	57,468 $2.02 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $556,001 - $973,363	-18,052 Reduced 54.27%	15,209 $496,000
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $1.09 Million - $1.46 Million	24,047 Added 260.98%	33,261 $1.83 Million
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $266,828 - $351,774	-6,344 Reduced 40.78%	9,214 $408,000
Q2 2022 Aug 11, 2022	BUY	$33.54 - $52.15 $17,776 - $27,639	530 Added 3.53%	15,558 $759,000
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $11,731 - $18,100	354 Added 2.41%	15,028 $731,000
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $197,244 - $254,063	-5,786 Reduced 28.28%	14,674 $626,000
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $238,104 - $357,991	9,272 Added 82.87%	20,460 $784,000
Q2 2021 Aug 12, 2021	BUY	$25.96 - $33.44 $290,440 - $374,126	11,188 New	11,188 $316,000

Others Institutions Holding HRMY

# of Institutions

278

Shares Held

44.8M

Call Options Held

130K

Put Options Held

46.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.1B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Harmony Biosciences Holdings, Inc. Transaction History